首页> 外文期刊>Stem cells international >Chimeric RNA in Cancer and Stem Cell Differentiation
【24h】

Chimeric RNA in Cancer and Stem Cell Differentiation

机译:癌症和干细胞分化中的嵌合RNA

获取原文
获取原文并翻译 | 示例
       

摘要

Gene fusions are considered hallmarks of cancer which can be produced by chromosomal rearrangements. These DNA-level fusion events may result in the expression of chimeric RNAs; however, chimeric RNAs can be also produced by intergenic splicing events. Chimeric transcripts created by the latter mechanism are regulated at the transcriptional level and thus present additional modes of action and regulation. They have demonstrated importance in normal cell physiology, and their dysregulation can induce oncogenesis and impact cell differentiation. In this review, we outline proven mechanisms through which intergenically spliced chimeric RNAs are involved in carcinogenesis. We highlight their similarity to canonical chimeric RNAs resulting from gene fusions as well as their unique qualities. Additionally, we review known roles of chimeric RNA in cell differentiation and propose means through which chimeric RNAs may be valuable as stage-specific markers or as targets for expression profiling.
机译:基因融合被认为是癌症的标志,可以通过染色体重排来生产。这些DNA水平融合事件可能导致嵌合RNA的表达;然而,嵌合RNA也可以由代际剪接事件产生。由后一种机制产生的嵌合转录物在转录水平上调节,因此存在额外的作用和调节模式。它们在正常细胞生理学中表现出重要性,并且它们的失调可以诱导肿瘤发生和冲击细胞分化。在本综述中,我们概述了经过验证的机制,可呈现糖化性嵌合RNA涉及致癌作用。我们突出了由基因融合和它们独特的品质引起的典型嵌合RNA的相似性。此外,我们审查嵌合RNA在细胞分化中的已知作用,并提出嵌合RNA可以是有价值的阶段特异性标记或作为表达分析的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号